BioCardia (BCDA) Profit After Tax (2010 - 2026)

BioCardia (BCDA) has reported Profit After Tax for 15 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Profit After Tax rose 21.28% year-over-year to -$1.6 million in Q2 2026; TTM through Jun 2026 was -$7.4 million, a 15.81% increase from a year earlier, with the FY2025 full-year figure at -$1.4 million, up 82.38% from the prior year.
• Profit After Tax was -$1.6 million for Q2 2026 at BioCardia, up from -$2.3 million in the prior quarter.
• Over five years, Profit After Tax peaked at -$1.5 million in Q3 2025 and troughed at -$3.5 million in Q1 2023.
• A 5-year average of -$2.4 million and a median of -$2.3 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax tumbled 37.12% in 2023 and surged 51.93% in 2024, its largest moves.
• Over 5 years, Profit After Tax stood at -$3.0 million in 2022, then jumped by 31.57% to -$2.1 million in 2023, then dropped by 10.81% to -$2.3 million in 2024, then surged by 35.41% to -$1.5 million in 2025, then decreased by 8.77% to -$1.6 million in 2026.
• The last three Profit After Tax figures came in at -$1.6 million (Q2 2026), -$2.3 million (Q1 2026), and -$1.5 million (Q3 2025), per Business Quant data.